Centaurus Financial, Inc. Standard Biotools Inc. Transaction History
Centaurus Financial, Inc.
- $1.4 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding LAB
# of Institutions
149Shares Held
263MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$139 Million9.76% of portfolio
-
Viking Global Investors LP58.7MShares$127 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$34.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$28.1 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $171M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...